BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36820536)

  • 1. The clinical course of untreated CIN2 (HPV16/18+) under active monitoring: A protocol of systematic reviews and meta-analysis.
    Han B; Yuan M; Gong Y; Qi D; Jiang T; Li J; Sun Y; Liu L
    Medicine (Baltimore); 2023 Feb; 102(6):e32855. PubMed ID: 36820536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of human papillomavirus (HPV) 16 and HPV18 viral loads for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) in a cohort of African women living with HIV.
    Segondy M; Ngou J; Kelly H; Omar T; Goumbri-Lompo O; Doutre S; Mayaud P; Didelot MN
    J Clin Virol; 2018; 99-100():79-83. PubMed ID: 29353074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.
    Vink FJ; Meijer CJLM; Hesselink AT; Floore AN; Lissenberg-Witte BI; Bonde JH; Pedersen H; Cuschieri K; Bhatia R; Poljak M; Oštrbenk Valenčak A; Hillemanns P; Quint WGV; Del Pino M; Kenter GG; Steenbergen RDM; Heideman DAM; Bleeker MCG
    Clin Infect Dis; 2023 Feb; 76(3):e827-e834. PubMed ID: 35686306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 9. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy and immunogenicity of therapeutic vaccines in the treatment of patients with high-grade cervical intraepithelial neoplasia associated with human papillomavirus: a systematic review protocol.
    Gonçalves CA; Lopes-Júnior LC; Nampo FK; Zilly A; Mayer PCM; Pereira-da-Silva G
    BMJ Open; 2019 Jul; 9(7):e026975. PubMed ID: 31320349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
    Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
    Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management.
    Wentzensen N; Walker J; Schiffman M; Yang HP; Zuna RE; Dunn ST; Allen RA; Zhang R; Sherman M; Gold MA; Wang SS
    Int J Cancer; 2013 Jan; 132(1):148-54. PubMed ID: 22488167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of
    Kremer WW; Berkhof J; Bleeker MC; Heideman DA; van Trommel NE; van Baal MW; Verhoeve HR; Meijer CJ; Kenter GG
    BMJ Open; 2019 Jul; 9(7):e029017. PubMed ID: 31289088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV16 and HPV18 genotyping triage in young women with borderline cytology or mild dyskaryosis: effect of age on genotype-specific risk of high-grade CIN.
    McKenna M; McMenamin M; McDowell A
    Cytopathology; 2016 Aug; 27(4):261-8. PubMed ID: 26873051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis.
    Arbyn M; Redman CWE; Verdoodt F; Kyrgiou M; Tzafetas M; Ghaem-Maghami S; Petry KU; Leeson S; Bergeron C; Nieminen P; Gondry J; Reich O; Moss EL
    Lancet Oncol; 2017 Dec; 18(12):1665-1679. PubMed ID: 29126708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population fraction of cervical neoplasia attributable to high-risk human papillomaviruses.
    Laukkanen P; Läärä E; Koskela P; Pukkala E; Virkkunen H; Lehtinen M
    Future Oncol; 2010 May; 6(5):709-16. PubMed ID: 20465386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age distribution of HPV genotypes in cervical intraepithelial neoplasia.
    Sideri M; Igidbashian S; Boveri S; Radice D; Casadio C; Spolti N; Sandri MT
    Gynecol Oncol; 2011 Jun; 121(3):510-3. PubMed ID: 21396686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.